Search

Your search keyword '"Czudnochowski N"' showing total 59 results

Search Constraints

Start Over You searched for: Author "Czudnochowski N" Remove constraint Author: "Czudnochowski N"
59 results on '"Czudnochowski N"'

Search Results

5. Broad betacoronavirus neutralization by a stem helix–specific human antibody

6. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

11. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

23. A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification.

24. Neutralization, effector function and immune imprinting of Omicron variants.

25. Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.

26. A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.

27. Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.

28. Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.

29. Workshop-based learning and networking: a scalable model for research capacity strengthening in low- and middle-income countries.

30. Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.

31. Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.

32. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement.

33. Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.

34. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.

35. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.

36. Broad betacoronavirus neutralization by a stem helix-specific human antibody.

37. Broad sarbecovirus neutralization by a human monoclonal antibody.

38. SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.

39. Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody.

40. Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape.

41. Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.

42. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.

43. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.

44. The structure of the endogenous ESX-3 secretion system.

45. Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria.

46. Chlamydia interfere with an interaction between the mannose-6-phosphate receptor and sorting nexins to counteract host restriction.

47. The mechanism of pseudouridine synthases from a covalent complex with RNA, and alternate specificity for U2605 versus U2604 between close homologs.

48. In human pseudouridine synthase 1 (hPus1), a C-terminal helical insert blocks tRNA from binding in the same orientation as in the Pus1 bacterial homologue TruA, consistent with their different target selectivities.

49. Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition.

50. Mechanistic insights into the translocation of full length HIV-1 Tat across lipid membranes.

Catalog

Books, media, physical & digital resources